Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience.
Saved in:
| Title: | Prevalence of omalizumab-resistant chronic urticaria and real-world effectiveness of dupilumab in patients with omalizumab-refractory chronic urticaria: a single-centre experience. |
|---|---|
| Authors: | Zhu, Catherine1 (AUTHOR), BinJadeed, Hessah2 (AUTHOR), Gabrielli, Sofianne1 (AUTHOR), Prosty, Connor1 (AUTHOR), Rahme, Elham3 (AUTHOR), Shand, Greg3 (AUTHOR), Fein, Michael4 (AUTHOR), Ben-Shoshan, Moshe5 (AUTHOR), Netchiporouk, Elena2 (AUTHOR) elena.netchiporouk@mail.mcgill.ca |
| Source: | Clinical & Experimental Dermatology. Oct2024, Vol. 49 Issue 10, p1227-1231. 5p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
